Combining VITEK
Agar dilution
Broth microdilution
Carbapenem resistance
Colistin susceptibility
Combined method
VITEK 2
Journal
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
ISSN: 1469-0691
Titre abrégé: Clin Microbiol Infect
Pays: England
ID NLM: 9516420
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
09
04
2018
revised:
17
09
2018
accepted:
18
09
2018
pubmed:
7
10
2018
medline:
23
8
2019
entrez:
7
10
2018
Statut:
ppublish
Résumé
The rise in carbapenem resistance among Gram-negative bacteria has renewed interest in colistin. Recently, the EUCAST-CLSI Polymyxin Breakpoints Working Group declared that broth microdilution (BMD) is the only valid method for colistin susceptibility testing. BMD is not easily incorporated into the routine work of clinical laboratories, and usually this test is incorporated serially, resulting in delayed susceptibility reporting. We tested a strategy of combining VITEK Colistin susceptibility for 364 clinical isolates was determined by VITEK The VME rate for VITEK Our method is simple to apply and allows rapid reporting of colistin susceptibility.
Identifiants
pubmed: 30291971
pii: S1198-743X(18)30636-0
doi: 10.1016/j.cmi.2018.09.014
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Culture Media
0
Agar
9002-18-0
Colistin
Z67X93HJG1
Types de publication
Journal Article
Langues
eng
Pagination
711-716Investigateurs
A Nutman
(A)
S Cohen-Percia
(S)
V Daitch
(V)
T Babich
(T)
R Andini
(R)
S Cuccurullo
(S)
A Cristinziano
(A)
G Cavezza
(G)
L Bertolino
(L)
G Giuffrè
(G)
R Giurazza
(R)
E Mallardo
(E)
R Zampino
(R)
Informations de copyright
Copyright © 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.